Literature DB >> 10703664

Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis.

Heinrich M Regele1, Edith Fillipovic1, Brigitte Langer1, Helga Poczewki1, Ilse Kraxberger1, Reginald E Bittner2, Dontscho Kerjaschki1.   

Abstract

Extensive flattening of podocyte foot processes and increased permeability of the glomerular capillary filter are the major pathologic features of minimal change nephrosis (MCN) and focal segmental glomerulosclerosis (FSGS). Adhesion proteins anchor and stabilize podocytes on the glomerular basement membrane (GBM), and presumably are involved in the pathogenesis of foot process flattening. Thus far, ao3 P,-integrin was localized to basal cell membrane domains. In this report, ao- and 3-dystroglycan (DG) were detected at precisely the sa-ne location by immunoelectron microscopy. and the presence of ac- and /-DG chains was confirmed by immunoblotting on isolated human glomeruli. Because the major DG binding partners in the GBM (laminin, agrin, perlecan), and the intracellular dystrophin analogue utrophin are also present in glomeruli, it appears that podocytes adhere to the GBM via DG complexes, similar to muscle fibers in which actin is linked via dystrophin and DG to the extracellular matrix. As with muscle cells, it is therefore plausible that podocytes use precisely actin-guided DG complexes at their "soles" to actively govern the topography of GBM matrix proteins. Expression of the a//3-DG complex was reported to be reduced in muscular dystrophies. and therefore a search for similar pathologic alterations in archival kidney biopsies from patients with MCN (it = 16) and FSGS (ni = 8) was conducted by quantitative immunoelectron microscopy. The density of a-DG on the podocyte's soles was significantly reduced to 25% in MCN, whereas it was not different in normal kidneys and FSGS. The expression of 3-DG was reduced to >50% in MCN, and was slightly increased in FSGS. Levels of DG expression returned to normal in MCN after steroid treatment (7 = 4). Expression of /3-integrin remained at normal levels in all conditions. These findings point to different potentially pathogenic mechanisms of foot process flattening in MCN and FSGS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10703664     DOI: 10.1681/ASN.V113403

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  41 in total

1.  Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.

Authors:  D Kerjaschki
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

3.  Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.

Authors:  Sanja Sever; Mehmet M Altintas; Sharif R Nankoe; Clemens C Möller; David Ko; Changli Wei; Joel Henderson; Elizabetta C del Re; Lianne Hsing; Ann Erickson; Clemens D Cohen; Matthias Kretzler; Dontscho Kerjaschki; Alexander Rudensky; Boris Nikolic; Jochen Reiser
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 4.  Cell-matrix adhesion of podocytes in physiology and disease.

Authors:  Norman Sachs; Arnoud Sonnenberg
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

Review 5.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

6.  alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.

Authors:  Mara Ferrandi; Daniele Cusi; Isabella Molinari; Lucia Del Vecchio; Cristina Barlassina; Maria Pia Rastaldi; Francesco Paolo Schena; Fabio Macciardi; Carmelita Marcantoni; Dario Roccatello; Luanne L Peters; Silvia Armelloni; Li Min; Laura Giardino; Deborah Mattinzoli; Claudio Camisasca; Fiorentina Palazzo; Paolo Manunta; Patrizia Ferrari; Giuseppe Bianchi
Journal:  J Mol Med (Berl)       Date:  2009-10-17       Impact factor: 4.599

7.  Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a.

Authors:  Maria Pia Rastaldi; Silvia Armelloni; Silvia Berra; Min Li; Marzia Pesaresi; Helga Poczewski; Brigitte Langer; Dontscho Kerjaschki; Anna Henger; Simone Monika Blattner; Matthias Kretzler; Rudiger Wanke; Giuseppe D'Amico
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

8.  Novel siRNA delivery system to target podocytes in vivo.

Authors:  Peter V Hauser; Jeffrey W Pippin; Cora Kaiser; Ronald D Krofft; Paul T Brinkkoetter; Kelly L Hudkins; Dontscho Kerjaschki; Jochen Reiser; Charles E Alpers; Stuart J Shankland
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

9.  Ligation of alpha-dystroglycan on podocytes induces intracellular signaling: a new mechanism for podocyte effacement?

Authors:  Nils P J Vogtländer; Henk Jan Visch; Marinka A H Bakker; Jo H M Berden; Johan van der Vlag
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

10.  Corticosteroids vs. corticosteroids plus cycloporin A in adult minimal changes disease.

Authors:  Dimitrios S Goumenos; Pantelitsa Kalliakmani; Eirini Savvidaki; John G Vlachojannis
Journal:  BMC Res Notes       Date:  2009-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.